THURSDAY, OCTOBER 22, 2026
7:00 am - 8:00 am
CONTINENTAL BREAKFAST
Ballroom B
8:15 am - 9:30 am
SCIENTIFIC SESSION I: Oncology I
Ballroom C
Steven J. Shichman, MD
NEAUA President
8:15 am - 9:30 am
SCIENTIFIC SESSION I: Oncology I
Ballroom C
(5 minute presentation, 2 minute discussion)
Genitourinary Events following Tri-modality-Therapy for Muscle invasive Bladder Cancer
Sarah J. Leick, MD1, Jillian M. Egan, MD
2, Linda V. Nguyen, MD
1, Xiu Liu, MS
1, Matthew F. Wszolek, MD
1, Richard J. Lee, MD, PhD
1, Jason A. Efstathiou, MD, DPhil
1, Adam S. Feldman, MD
1.
1Massachusetts General Hospital, Boston, MA, USA, 2Albany Med Health System, Albany, NY, USA.
Predictive Capabilities of a Machine Learning-Driven, Nanoscale Imaging Platform for Non-Muscle Invasive Bladder Cancer Diagnosis in a Prospective, Cross-Sectional, Case-Controlled Study
Amir Monemian, PhD
1, Jean Pham, MS
1, Son Pham, MS
1, Zhiying Xie, PhD
1, Nadia Makarova, PhD
1, Louis Liou, MD, PhD
2,
Emily Huang, MD3, Nnamdi Onochie, BS
3, Matthew Mossanen, MD, MPH
3.
1Cellens, Inc., Boston, MA, USA, 2Emerson Hospital, Concord, MA, USA, 3Mass General Brigham, Boston, MA, USA.
Comparative Cost Analysis of Emerging Intravesical Therapies Vs Radical Cystectomy for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer
Peter Aziz, M.S.1, Angela P. Monero, M.S.
2, Peter Somboonsong, B.S.
2, Anthony Khoudary, B.A./M.S.
1, Daniel Edwards, DO, FACOS, FACS
1.
1Drexel University College of Medicine, Wyomissing, PA, USA, 2Drexel University College of Medicine, Philadelphia, PA, USA.
Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer: Interim Analysis of a Prospective Randomized Trial
Samuel S. Iofel, BA1, Tai Nguyen, BS
1, Namit D. Sambare, BS
2, Travis B. Sullivan, MS
3, Zhibang Lin, MS
3, Tasneem Z. Rizvi, PhD
3, Matthew B. Clements, MD, MS
3.
1Tufts University School of Medicine, Boston, MA, USA, 2UMass Chan Medical School, Worcester, MA, USA, 3Lahey Hospital and Medical Center, Burlington, MA, USA.
Is Peri-Renal Fat Thickness of the Contralateral Kidney as Measured on Pre-Operative Imaging Associated With Progression to Chronic Kidney Disease After Radical Nephrectomy?
Andrew Harper Williams, MD, Ankur Choksi, MD, Graham Kupsaw, BS, Gabriela Nieto Blanco, BS, Boris Gershman, MD, Peter Chang, MD, Andrew Wagner, MD.
BIDMC, Boston, MA, USA.
Active surveillance prior to radical prostatectomy is not associated with rates of biochemical recurrence
Likhit Agrawal, BS1, Rebekka S. Garcia, MPH
2, Andrew W. Hahn, MD
2, Taryn Ellis, MD
2, Brian F. Chapin, MD
2, John W. Davis, MD
2, John W. Ward, MD
2, Curtis Pettaway, MD
2, Lisly Chery, MD
2, Daniel Igel, MD
2, Patricia Troncoso, MD
2, Miao Zhang, MD
2, Ethan Bui, BS
1, Avani Shepard, BS
1, Janis Busse, BS
1, Justin R. Gregg, MD
2.
1McGovern Medical School at UT Health Houston, Houston, TX, USA, 2MD Anderson Cancer Center, Houston, TX, USA.
Primary Care Physician Specialty and Prostate Cancer Screening: A Propensity Score-Matched Cohort Study
Eric J. Macdonald, MD1, Rumel Mahmood, PhD
2, Thaise Uzeda, MD
1, Benjamin Green, MD
1, Andrew Williams, MD
1, Michelle Shabo, MD
1, Benjamin Allar, MD
1, Stephanie Hastings, MD
3, Boris Gershman, MD
1, Gezer Ortega, MD
4, Heidi Rayala, MD, PhD
1.
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2OHSU, Portland, OR, USA, 3Cambridge Health Alliance, Cambridge, MA, USA, 4Mass General Brigham, Boston, MA, USA.
Accuracy of Radionics to Diagnose Progression of Prostate Cancer in Patients Undergoing Active Surveillance: A Systematic Review and Diagnostic Meta-Analysis
Thaise Sestelo Uzeda, MD1, Mohammed Abdullah Ramadhan, MBChB
2, Giovanni B. Torri, MD
3, Giulia Almiron da R. Soares, MD
4, Lucas G. C. R. de Amorim, MD
5, Giovana Veiga Gomes, .
6, Guilherme Melchior Maia Lopes, .
7, Manuel Guillermo Ruelas Martinez, MD
8, Vinay Anant Duddalwar, MD
9, Andr Luis de Castro Abreu, MD
9, Barbara Vieira Lima Aguiar Mel o, MD, PhD
10.
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2Jaber Al Ahmed Al Sabah Hospital, Kuwait City, Kuwait, 3University of Florida, Miami, FL, USA, 4Universidade Metropolitana de Santos, Santos, Brazil, 5Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 6Universidade Municipal de S o Caetano do Sul, S o Caetano do Sul, Brazil, 7FMABC, Santo Andr , Brazil, 8Tecnologico de Monterrey, Monterrey, Mexico, 9University of Southern California, Los Angeles, CA, USA, 10University of S o Paulo, S o Paulo, Brazil.
25 Years of Active Surveillance for Prostate Cancer: Is There an Increased Burden of Treatment in Those Who Progress?
Noa Ferziger, BA, Lampros Pantazis, MD, Rajveer Kaur, BS, Emily Huang, MD, Keyan Salari, MD, PhD, Adam S. Feldman, MD, MPH.
Massachusetts General Hospital, Boston, MA, USA.
Complementary Role of PSMA PET/CT in Detecting Clinically Significant Prostate Cancer Recurrence After Focal Therapy
Anthony Zhang, BS, Nishan Sohoni, BS, MS, Andrea Lopez-Sanmiguel, MD, Preston C, Sprenkle, MD.
Yale University School of Medicine, New Haven, CT, USA.
8:15 am - 9:30 pm
CONCURRENT POSTER SESSION I: Benign:
Mtg Room 24/25
(30 min viewing, 2-minute presentation, 2-minute discussion)
Urinary Biomarkers Associated with Radiation Cystitis Hyperbaric Oxygen Therapy Outcomes
Ambrose Orr, MD1, Richard Bellemare, MD
1, Daniel Mielcarz, PhD
2, Suwen Wu, MS
3, Janet Peacock, PhD
4, Pamela Hannigan, RN
1, Lawrence Bornt, RN
1, William Bihrle, III, MD
1, Sladjana Skopelja-Gardner, PhD
5, Duncan Morhardt, MD, PhD
1, Jay Buckey, MD
5, Rachel Moses, MD, MPH
1.
1Dartmouth Hitchcock Medical Center, Section of Urology, Lebanon, NH, USA, 2DartLab, Dartmouth Cancer Center, Geisel School of Medicine, Hanover, NH, USA, 3Geisel School of Medicine, Dartmouth College, Dept of Epidemiology, Lebanon, NH, USA, 4Geisel School of Medicine, Dartmouth College, Dept of Epidemiology, Hanover, NH, USA, 5Dartmouth Health, Dept of Medicine, Geisel SOM at Dartmouth College, Lebanon, NH, USA.
The Whirlpool Sign Revisited: Limited Additional Predictive Value When Screening For Testicular Torsion at a Stand-Alone Pediatric Institution
Emily May, MD1, Corey Shafer, MD
1, Lindsey Webb, MD
1, Kelly White, BS
2, Arianna Matz, MD
1, Oluwadamilola Egbewole, BDS, MPH
3, Daniel Herz, MD
3, Anne Dudley, MD
3, Courtney Rowe, MD
3.
1University of Connecticut, Farmington, CT, USA, 2University of Connecticut Medical School, Farmington, CT, USA, 3Connecticut Children's Medical Center, Hartford, CT, USA.
Predicting Post-Operative IPP Infections: Machine Learning Risk Stratification and Validation
Muhammad Hammad, MBBCh
1, Martin Gross, MD
2,
Nicholas Moll, MD2, Samuel Ivan, MD
3, Elia Chawareb, MD
1, Yash Kadakia, MD
1, Faysal Yafi, MD
1, Thairo Pereira, MD
4, Jacob Good, MD
5, Helen Bernie, MD
5, Nicklas Sarantos, MD
6, Aaron Lentz, MD
6, Alfredo Suarez-Sarmiento, Jr., MD
7, Paul Perito, MD
7, Joshua Schammel, MD
8.
1UC Irvine, Irvine, CA, USA, 2Dartmouth Hitchcock Medical Center, Lebanon, NH, USA, 3Fox Chase, Philadelphia, PA, USA, 4University of Rochester, Rochester, NY, USA, 5Indiana University, Indianapolis, IN, USA, 6Duke University, Durham, NC, USA, 7Perito Urology, Coral Gables, FL, USA, 8Albany Medical College, Albany, NY, USA.
Incidence and Management of Post-Cystectomy Pelvic Organ Prolapse Among a Contemporary, Multi-Institutional Cohort
John Ernandez, MD, Vanessa Lukas, MD, Yu Zheng, MD.
Department of Urology, Brigham and Women's Hospital, Boston, MA, USA.
Transcriptomic analysis reveals distinct molecular pathways in lichen sclerosus-related urethral stricture disease
Amy Zheng, MD1, Lingge Yu, MS
2, Jennifer Beane-Ebel, PhD
2, Eric Burks, MD
3, Travis Sullivan, MS
1, Kimberly Rieger-Christ, PhD
1, Alex Vanni, MD
1.
1Lahey Hospital & Medical Center, Burlington, MA, USA, 2Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA, 3Boston Medical Center, Boston, MA, USA.
Omphalocele Reduction in OEIS: Safety and Feasibility of a Custom Hydrocolloid Dressing Prior to Operative Closure
Noa Ferziger, BA, Aisha L. Siebert, MD, PhD, Mark A. Fleming II, MD, William Law, MD, Evalynn Vasquez, MD, MBA, Ted Lee, MD, MSc, Belinda Dickie, MD, PhD.
Boston Children's Hospital, Boston, MA, USA.
Correlation Between MRI and Pathologic Measurements of the Prostate Resection Zone
Priscilla A. McElhinney, MS1, Patrick J. Soonthornprapuet, BS
2, Wyatt LePenske, MS
2, Kimberly A. Maciolek, MD
3, Lori B. Lerner, MD
2.
1Boston University School of Medicine, Boston, MA, USA, 2VA Boston Healthcare System, West Roxbury, MA, USA, 3University of Virginia, Charlottesville, VA, USA.
Robot Assisted Surgical Repair Of Nutcracker Syndrome: A Case Series
Mahan Najhawan, MD1, Deeba Zadeh, BS
2, Amy Rao, MD
3, Chakaris Neal, MD
3, Godfrey Parkerson, MD
3, Michael Maddox, MD
3.
1UMass Chan/Ochsner Clinic Foundation, Worcester, MA, USA, 2University of Queensland - Ochsner Clinical School, New Orleans, LA, USA, 3Ochsner Clinic Foundation, New Orleans, LA, USA.
Ejaculatory function and bother after the ProVee prostatic urethral stent for benign prostatic hyperplasia: Results from the ProVIDE Study
Muhieddine Labban, MD1, Lori Lerner, MD
2.
1Brigham and Women's Hospital, BOSTON, MA, USA, 2VA Boston Healthcare, BOSTON, MA, USA.
The Good, the Bad, and the Useful of CT, MRI, and TRUS in Assessing Prostate Volume
Daniel Givner, MD1, Caroline Sha, BS
2, Wyatt L. Penske, BS
3, Kimberly A. Maciolek, MD
4, Lori Lerner, MD
3.
1Boston Medical Center, Boston, MA, USA, 2Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA, 3VA Boston Healthcare System, Boston, MA, USA, 4University of Virginia, Charlottesville, VA, USA.
Modeling Intensity Predicts Timing of Resolution in Penile Curvature Management
Benjamin H. Rosenfeld, MD1, Britney L. Atwater, MD
2, Muhammed A. Hammad, MBBCh
3, Martin S. Gross, MD
1.
1Dartmouth Health, Lebanon, NH, USA, 2University of South Florida, Tampa, FL, USA, 3University of California, Irvine, Irvine, CA, USA.
9:30 am - 10:00 am
PANEL: AI in Urology
Ballroom C
10:00 am - 10:30 am
COFFEE BREAK
Ballroom B
10:30 am - 12:00 pm
CONCURRENT SCIENTIFIC SESSION II: Stones / Endourology
Ballroom C
(5 minute presentation, 2 minute discussion)
Association Between Area Deprivation Index and Disparities in Acute Stone Treatment and Prevention: Findings from the AQUA Registry
Muhieddine Labban, MD1, Emily Galen, MS
2, Rachel Mbassa, MS
3, George Haleblian, MD
1, Daniel Wollin, MD, MS
1.
1Brigham and Women's Hospital, BOSTON, MA, USA, 2American Urological Association, LINTHICUM, MD, USA, 3American Urological Association Statistical Services, LINTHICUM, MD, USA
Downstream Costs of Traditional and Suction Ureteral Access Sheaths: A Decision Analysis
Jonathan J. Song, BS
1,
Samuel Z. Lee, BA1, Juliana Villanueva Congote, MD
2, Daniel A Wollin A. Wollin, MD
2.
1Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA, 2Department of Urology, Brigham and Women's Hospital, Boston, MA, USA.
Multicenter Comparison of Stone Clearance with CVAC Aspiration Ureteroscope and Flexible and Navigable Ureteral Access Sheaths
Jackson Cabo,
1,
Stephen A. Harrington2 Vernon M. Pais
2, Levi Bowers
3, Nicole Miller
3, Ryan Hsi
3, Runhan Ren
4, Ben Chew
4, Connor Forbes
4, Austin Chien
5, Jack Hannallah
5, David Tzou
5, Daniel Turin
6, Aaron Potretzke
6, Kevin Wymer
6, Garrett Ungerer
6, Kevin Koo
6, Christopher Ballantyne
1, Adam Ostergar
1, Mitchell Humphreys
1, Karen Stern
1.
1Mayo Clinic, Phoenix, AZ, USA, 2Dartmouth Health Medical Center, Lebanon, NH, USA, 3Vanderbilt University Medical Center, Nashville, TN, USA, 4University of British Columbia, Vancouver, BC, Canada, 5University of Arizona, Tuscon, AZ, USA, 6Mayo Clinic, Rochester, MN, USA.
Microenvironment-Specific Zinc Enrichment and Structural Heterogeneity in Human Kidney Stones
Benjamin Greenfield, MS1, Jorge Mena, MD
2, Sudarshan Srirangapatanam, MD
2, Misun Kang, PhD
2, Samuel Webb, PhD
3, Marshall Stoller, MD
2, Sunita Ho, PhD
2.
1Tufts University School of Medicine, Boston, MA, USA, 2University of California, San Francisco, San Francisco, CA, USA, 3Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory,, Menlo Park, CA, USA.
Kidney Stone Growth Parameters Following Anti-Obesity Treatment with GLP-1 Receptor Agonists and Bariatric Surgery
Theodoros Karanikolas, BA1, Jonah Tripp, BA, MPH
2, Hudson Jakubowicz, BA
2, Valmic Patel, MD
1, Jake Drobner, MD
1, Dima Raskolnikov, MD
1, Alexander Small, MD
1.
1Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA, 2Albert Einstein College of Medicine, Bronx, NY, USA.
Preoperative and Perioperative Predictors of Adverse Clinical Outcomes after Thulium Fiber Laser Enucleation of the Prostate
Daniel Sanford, MD, Jarrett Noakes, BS, Jack Mulcrone, BA, Raymond Chiang, BS ScM, Andrew Tompkins, MD, Samuel Eaton, MD.
Brown University Health, Providence, RI, USA.
A Retrospective Analysis of Stone Events and Treatment Following Medical vs Surgical Management of Primary Hyperparathyroidism: A National Database Review
Jack William Pearce, B.S.1, Nicholas Khoo, B.S.
1, Patrick Flaherty, B.S.
1, Jake Bleau, B.S.
1, Sidney Gregorek, B.A.
1, Benjamin Rubin, B.S.
1, Clara Goebel, B.A.
1, Brian H. Irwin, MD
2, Jenna Winebaum, MD
2, Richard T. Grunert, MD
2, Mohammad Mohaghegh, MD
2.
1University of Vermont College of Medicine, Burlington, VT, USA, 2University of Vermont Medical Center, Burlington, VT, USA.
Tamsulosin use for suspected urinary stone disease in pregnancy is characterized by empiric prescribing and limited documentation of adherence
Aleksandra M. Golos, BS1, Alejandra Barreto, MPH
1, Esther Chung, BS
2, Ellen M. Cahill, MD
1, Marianne Casilla-Lennon, MD
1.
1Yale School of Medicine, New Haven, CT, USA, 2Frank H. Netter School of Medicine at Quinnipiac University, North Haven, CT, USA.
Optimizing Endourologic Stone Removal: A Comparison of CVAC and FANS Techniques
Rachael Elizabeth Muggleton, BS1, Rajbabu Krishnamoorthy, MD
2.
1Lake Erie College of Osteopathic Medicine, ELMIRA, NY, USA, 2The Guthrie Clinic, Sayre, PA, USA.
10:30 am - 12:00 pm
CONCURRENT POSTER SESSION II: Oncology I
Mtg Room 24/25
(30 min viewing, 2-min presentation, 2-min discussion)
Does Deprivation Equal Complications? How Socioeconomic Status Predicts Radical Cystectomy Outcomes
Adam Jeffrey Cole, MD1, Emilie Platteter, BS
2, Randie White, MD
3, Danniel Lassman, BA
4, Michael Morandini, BS
4, Aniket Hingnekar, BS
5, Stephen Ryan, MD
1, Matthew Hayn, MD
1, Jesse Sammon, DO
1, Vitaly Margulis, MD
5, Jeffrey Howard, MD, PhD
1.
1Maine Medical Center, Portland, ME, USA, 2University of New England, Portland, ME, USA, 3Vanderbilt, Nashville, TN, USA, 4Tufts University, Boston, MA, USA, 5University of Texas Southwestern Medical Center, Dallas, TX, USA.
Frailty and the Comparative Effectiveness of Robotic-Assisted Radical Cystectomy Versus Open Radical Cystectomy in Older Adults
Jamil Almohtasib, MD1, Joseph Black, MD
2, Sumedh Kaul, MS
1, Aaron Fleishman, MPH
1, Peter Chang, MD
1, Andrew Wagner, MD
1, Joaquim Bellmunt, MD
3, Ruslan Korets, MD
1, Aria F. Olumi, MD
1, Boris Gershman, MD
1.
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2MD Anderson Cancer Center, Houston, TX, USA, 3Dana-Farber Cancer Institute, Boston, MA, USA.
Prospective pilot and feasibility study of a blood-based biomarker of aging in patients with invasive bladder cancer undergoing radical cystectomy
Benjamin T. Ristau, MD, MHA1, Chia-Ling Kuo, PhD
2, Shangshu Zhao, PhD
2, Laura Haynes, PhD
2, George A. Kuchel, MD
2.
1UConn Health, Farmington, CT, USA, 2University of Connecticut Health Center, Farmington, CT, USA.
Spatial Transcriptomics of Aggressive Micropapillary, Plasmacytoid, and Sarcomatoid Urothelial Carcinoma Reveals Distinct Molecular Landscapes
Ting Zhao, MD
1, Cole Nawrocki, BA
2, Alfred Anthony Barney, IV, MS
1, Linjie Xiong, MD
1, Linda T. Nieman, PhD
3, Philip J. Saylor, MD
1, Michael L. Blute, MD
1, David T. Miyamoto, MD, PhD
1, David T. Ting, MD
1,
Douglas M. Dahl, MD1, Chin-Lee Wu, MD, PhD
1.
1Massachusetts General Hospital, Boston, MA, USA, 2Mass General Bringham Cancer Institute, Boston, MA, USA, 3Mass General Brigham Cancer Institute, Boston, MA, USA.
Downstream Costs of Routine Single-Instillation Gemcitabine vs Mitomycin C After Resection of Low-Risk Non-Muscle Invasive Bladder Cancer
Jonathan J. Song, BS
1,
Winston Tan, BS1, Carissa Chu, MD
2, Mark Preston, MD, MPH
3, Daniel A. Wollin, MD, MS
3.
1Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA, 2University of California San Francisco, San Francisco, CA, USA, 3Brigham and Women's Hospital, Boston, MA, USA.
Safety of Minimally-Invasive Partial vs Radical Nephrectomy for cT1-T2 Renal Masses: An NSQIP Analysis
Jonathan Song, BA,
Nancy Donohoo, BA, Samuel Lee, BA, James Jones, III, MD, Daniel Chen, MD, Frank Meng, PhD, Mark Katz, MD, David Wang, MD.
Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Oncologic and Safety Outcomes of Microwave Ablation Versus Partial Nephrectomy for Small Renal Masses: Systematic Review and Meta-Analysis
Thaise Sestelo Uzeda, MD1, Giulia Almiron da R. Soares, MD
2, Phillip Anderson da Silva Avelino, BS
3, Murilo Ribeiro Sanches, MD
4, Heidi J. Rayala, MD, PhD
1, Barbara Viera Lima Aguiar Mel o, MD, PhD
5.
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2Metropolitan University of Santos, Santos, Brazil, 3Federal University of Rio Grande do Norte, Natal, Brazil, 4Federal University of Goias, Goiania, Brazil, 5University of S o Paulo, S o Paulo, Brazil.
High-Risk Decipher Score Independently Predicts Recurrence After Primary Focal Therapy Within a Localized Prostate Cancer Cohort
Anthony Zhang, BS, Nethusan Sivanesan, BS, Andrea Lopez-Sanmiguel, MD, Preston C. Sprenkle, MD.
Yale University School of Medicine, New Haven, CT, USA.
Pathological upgrading from biopsy Gleason score 3+4 (Grade Group 2) to final radical prostatectomy pathology
Shulin Wu, MD, PhD, Sharron X. Lin, PhD, Alfred Anthony Barney, IV, MS, Michelle M. Kim, MD, Mukesh G. Harisinghani, MD, Adam S. Feldman, MD, MPH, Chin-Lee Wu, MD, PhD, Douglas M. Dahl, MD.
Massachusetts General Hospital, Boston, MA, USA.
Racial Disparities in Referral Rates and Appointment Completion among Black and White men with Elevated Prostate-Specific Antigen; 7-year Outcomes of Duke Cancer Institute PSA-Screening Algorithm
Mahdi Mottaghi, MD, Sudharshanan Balaji, MBBS, Jingchen Chai, MS, Alireza Ghoreifi, MD, Samantha M. Thomas, MS, Sriram Deivasigamani, MBBS, Eric S. Adams, MD, Mark Gregory, MS, Steven Patierno, MD, PhD, Andrew J. Armstrong, MD, Daniel J. George, MD, Rajan T. Gupta, MD, Glenn M. Preminger, MD, Judd W. Moul, MD, Kevin Shah, MD, Kevin C. Oeffinger, MD, Thomas J. Polascik, MD.
Duke, Durham, NC, USA.
Impact of Polygenic Risk Scores on Prostate Cancer Detection in the Prostate Cancer Genetic Risk Evaluation and Screening Study (PROGRESS)
Katherine Merport, BA1, Himanshu Patankar, BS
2, Rajveer Kaur, BA
2, Aileen J. Feng, BA
2, Andrew E. Amini, MD
2, Margaret R. O'Dea, CNP
2, Shelley R. McCormick, MS, CGC
3, Linda H. Rodgers-Fouche, MGC, CGC
3, Keyan Salari, MD, PhD
2.
1UMass Chan Medical School, Worcester, MA, USA, 2Department of Urology, Mass General Brigham, Boston, MA, USA, 3Center for Cancer Risk Assessment, Mass General Brigham Cancer Institute, Boston, MA, USA.
Predictors of Upgrading between MR-Visible vs Invisible Gleason Grade Group 1 Prostate Cancer on Active Surveillance
Theodoros Karanikolas, BA1, Victoria Dai, BS
2, Morgan Joseph, BS
1, Stephen Reese, MD
1, Kara Watts, MD
1.
1Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA, 2Albert Einstein College of Medicine, Bronx, NY, USA.
Too Little, Too Late? Characterizing PSA Screening History in Men with De Novo Metastatic Prostate Cancer
Angelo Blancaflor, BS1, Jack Mulcrone, BS
1, Aaron Duong, BS
2, Alejandro Rivera, BS
2, Michael Chang, BS
2, Grace Hyland, BS
2, Luke Maietta, BS
2, Natalia Alzate, BS
2, Taylor Braunagel, MS
2, Anthony Mega, MD
3, Elias Hyams, MD
2.
1The Warren Alpert Medical School of Brown University, Providence, RI, USA, 2Brown University Health, Minimally Invasive Urology Institute, Providence, RI, USA, 3Brown University Health, Division of Medical Oncology, Providence, RI, USA.
Prognostic Value of a Negative mpMRI during Active Surveillance for Prostate Cancer
Lampros Pantazis, MD, Hersh H. Bendre, MD, Rajveer Kaur, BSc, Aileen J. Feng, BA, Alexandra Hunter, BA, Neel Patel, MBBS, MPH, Rory L. Cochran, MD, PhD, Mukesh Harisinghani, MD, Douglas M. Dahl, MD, Matthew Wszolek, MD, Jason Efstathiou, MD, DPhil, Keyan Salari, MD, PhD, Adam S. Feldman, MD, MPH.
Massachusetts General Hospital, Boston, MA, USA.
Differential Gene Expression for ccRCC Tumors with Varied Clinical Outcomes
Molly J. Parries, MD, Kailey Hooper, BS, Eric Burks, MD, Travis Sullivan, MS, Kimberly Rieger-Christ, PhD.
Lahey Hospital and Medical Center, Burlington, MA, USA.
12:00 pm - 12:30 pm
SUO GUEST SPEAKER
Ballroom C
Bernard Bochner
12:30 pm - 12:45 pm
AMERICAN BOARD OF UROLOGY UPDATE
Ballroom C
12:45 pm - 1:00 pm
SES Updates: PPC / SAC
Ballroom C
1:00 pm - 2:00 pm
LUNCH SYMPOSIUM
2:00 pm - 2:30 pm
POSTER VIEWING TIME
AUA Advocey Summit Reports
Ballroom Foyer
2:30 pm - 3:30 pm
SCIENTIFIC SESSION III A: Infertility, Sexual Dysfunction and Men's Health
Ballroom C
(5 minute presentation, 2 minute discussion)
Deployed Inflatable Penile Prosthesis (IPP) Risk Calculator: A Machine Learning Platform for Multi-Center Validation of Three Predictive Models
Muhammed Hammad, MBBCh
1, Martin Gross, MD
2,
Nicholas Moll, MD2, Samuel Ivan, MD
3, Elia Chawareb, MD
1, Yash Kadakia, MD
1, Faysal Yafi, MD
1, Thairo Pereira, MD
4, Jacob Good, MD
5, Helen Bernie, DO
6, Nicklas Sarantos, MD
7, Aaron Lentz, MD
7, Alfredo Suarez-Sarmiento, Jr., MD
8, Paul Perito, MD
8, Joshua Schammel, MD
9, Charles Welliver, MD
9, Zayda Dominick, MD
10, Ketch Cowan, MD
10, Anand Shridharani, MD
10, Brian Im, MD
11, Paul Chung, MD
11, Vi Nguyen, MD
12, Michael Hsieh, MD
12, Bryce Baird, MD
13, Allen Morey, MD
13.
1University of California, Irvine, Irvine, CA, USA, 2Dartmouth Hitchcock Medical Center, Lebanon, NH, USA, 3Fox Chase, Philadelphia, PA, USA, 4University of Rochester, Rochester, NY, USA, 5Indiana University, Indianapolis, IN, USA, 6Indiana University, Carmel, IN, USA, 7Duke University, Durham, NC, USA, 8Perito Urology, Coral Gables, FL, USA, 9Albany Medical College, Albany, NY, USA, 10Erlanger Health System, Chattanooga, TN, USA, 11Thomas Jefferson University, Philadelphia, PA, USA, 12UC San Diego, San Diego, CA, USA, 13Urology Clinics of North Texas, Dallas, TX, USA.
Machine Learning Prediction of Non-Infectious Post-IPP Complications Utilizing a Large Multicenter Collaborative: Unified Taxonomy and Validation
Ambrose Orr, MD1, Martin Gross, MD
1, Muhammed Hammad, MBBS, MSc
2, S Ivan, MD
3, Bailey Carter, MD
1, Elia Chawareb, MD
2, Nicholas Moll, MD
1, Faysal Yafi, MD
2, Thairo Pereira, MD
4, Jacob Good, MD
4, Helen Bernie, MD
4, Aaron Lentz, MD
5, Alfredo Suarez-Sarmiento, MD
6, Paul Perito, MD
6, David Barham, MD
7, Mike Hseih, MD
8, Jay Simhan, MD
3.
1Dartmouth Hitchcock Medical Center, Lebanon, NH, USA, 2University of California Irvine, Dept of Urology, Orange, CA, USA, 3Fox Chase Cancer Center, Philadelphia, PA, USA, 4Indiana University, Indianapolis, IN, USA, 5Duke University, Durham, NC, USA, 6Perito Urology, Coral Gables, FL, USA, 7Brooke Army medical Center, Fort Sam, Houston, TX, USA, 8University of California San Diego, Dept of Urology, San Diego, CA, USA.
Simulation-based training enhances APP preparedness in ischemic priapism management: Results from an inaugural regional course
Andrew Kehm, BS
1, Ilene Staff, PhD
2, Tara McLaughlin Proto, PhD
3, Brenden Race, BS
4, Thomas Nowicki, MD
4,
Jared Bieniek, MD3.
1Frank Netter School of Medicine, Quinnipiac University, North Haven, CT, USA, 2Research Department, Hartford HealthCare, Hartford, CT, USA, 3Tallwood Urology & Kidney Institute, Hartford HealthCare, Hartford, CT, USA, 4Center for Education, Simulation, and Innovation, Hartford HealthCare, Hartford, CT, USA.
GLP-1 Receptor Agonist Addition to Testosterone Replacement Therapy is Associated with Reduced Erectile Dysfunction: A Propensity-Matched Analysis
Samuel Z. Lee, BA1, Winston Tan, BS
1, Nancy Donohoo, BS
1, Lori Lerner, MD
2, Rachel Greenberg, MD
2.
1Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA, 2VA Boston Healthcare System, Department of Surgery, West Roxbury, MA, USA.
Intraoperative and Postoperative Practice Patterns among Penile Prosthesis Surgeons
Ryan Frazier, M.D.
1, Elia Abou Chawareb, M.D.
2, Muhammed Hammad, MBBCh
2,
Stephen A. Harrington, M.D.3, Ambrose Orr, M.D.
3, Benjamin Rosenfeld, M.D.
3, Nicholas Moll, M.D.
3, Samuel Ivan, M.D.
4, Jay Simhan, M.D.
4, Faysal Yafi, M.D.
2, David Barham, M.D.
1, Martin S. Gross, M.D.
3.
1Brooke Army Medical Center, San Antonio, TX, USA, 2University of California, Irvine, Orange, CA, USA, 3Dartmouth Hitchcock Medical Center, Lebanon, NH, USA, 4Fox Chase Cancer Center, Philadelphia, PA, USA.
Development and Validation of a Machine Learning Prediction Model for Inflatable Penile Prosthesis Intraoperative Complications to Improve Preoperative Counseling
Bailey Carter, M.D.1, David Han, MS
2, Muhammed Hammad, MBBCh
3, Martin Gross, MD
1, Samuel Ivan, MD
4, Justin Schneider, BA
3, Jonathan Prunean, .
3, Elia Elia Abou Chawareb, MD
3, Babak Azad, MD
5, Daniel Swerdloff, MD
6, Jake Miller, MD
3, Robert Andrianne, MD, PhD
7, Arthur Burnett, MD
8, Kelli Gross, MD
9, Georgios Hatzichristodoulou, MD
10, James Hotaling, MD, MS
9, Tung-Chin Hsieh, MD
11, Aaron Lentz, MD
12, Daniar Osmonov, MD
13, Sung Hun Park, MD
14, Ian Pearce, BMBS
15, Paul Perito, MD
16, Hossein Sadeghi-Nejad, MD
17, Faysal Yafi, MD
3, Jay Simhan, MD
4.
1Dartmouth Hitchcock Medical Center, Lebanon, NH, USA, 2The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth College, Lebanon, NH, USA, 3University of California, Irvine, Irvine, CA, USA, 4Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA, 5Tulane University School of Medicine, New Orleans, LA, USA, 6Northwell Health, Brooklyn, NY, USA, 7University Hospital of Li ge, Li ge, Belgium, 8Johns Hopkins School of Medicine, Lutherville, MD, USA, 9University of Utah, Salt Lake City, UT, USA, 10Martha-Maria Hospital Nuremberg, Nuremberg, Germany, 11University of California, San Diego, San Diego, CA, USA, 12Duke Health, Raleigh, NC, USA, 13University Hospital Schleswig-Holstein, L beck, Germany, 14Sewum Prosthetic Urology, Seoul, Korea, Republic of, 15Manchester University NHS Foundation Trust, Manchester, United Kingdom, 16Perito Urology, Coral Gables, FL, USA, 17New York University, New York, NY, USA.
Comorbidities and Treatment Patterns Differ in Young Menwith Peyronie's Disease
Peris R. Castaneda, MD,
Amy Zheng, MD, Samantha Freeman, MD, Alex Vanni, MD.
Lahey Hospital and Medical Center, Burlington, MA, USA.
Use of Nerve Protector Sheath During Robotic Assisted Laparoscopic Prostatectomy Not Associated with Improved Patient Reported Erectile Function or Continence - A Single Center, Single Surgeon Retrospective Review
Austin Freedman, BS, Rutul Patel, MD, Theodoros Karanikola, BA, Pedro Maria, MD.
Albert Einstein College of Medicine, NEW YORK, NY, USA.
2:30 pm - 3:30 pm
CONCURRENT SCIENTIFIC SESSION III B: BPH/General/Best Practice
Mtg Room 24/25
(5 minute presentation, 2-minute discussion)
When Less Is More: Assessing Irrigant and Plastic Waste During Endoscopic Urologic Surgeries
Austin Freedman, BS, So Yeon Pak, MD, Ilir Agalliu, MD, ScD, Alexander Small, MD, Dima Raskolnikov, MD, Kara Watts, MD.
Albert Einstein College of Medicine, New York, NY, USA.
Early Patient-Reported Outcomes Following Contemporary BPH Procedures: A Prospective Multicenter Comparison of TURP, HoLEP, Aquablation, and PAE
Ra'ad Al-Faouri, MD MMSc, Thaise Uzeda, MD, Andrew Williams, MD, Jaleta Ahmed, MS, Christian Schaufler, MD, Michelle Shabo, MD, Shaun Wason, MD, Ruslan Korets, MD, Heidi J. Rayala, MD/PHD.
Beth Israel Deaconess Medical Center, Boston, MA, USA.
Standardizing the use of transperineal bulbar urethral ultrasonography to identify patients with pre-operative urethral fragility: Establishing normative data for a pilot study
Philip Olson, MD1, Ilene Staff, PhD
2, Tara McLaughlin, PhD
2, Joseph Tortora, MS
2, Kevin Pinto, BS
2, Richard Kershen, MD
2.
1UConn Health, Farmington, CT, USA, 2Hartford Healthcare, Hartford, CT, USA.
Improving Access to Speciality Care Through Electronic Consultation: A Single-Center Evaluation of eConsult Utilization and Efficiency
Winston Tan, BS1, Wilson Dong, BS
1, Samuel Z. Lee, BA
1, Joseph Y. Liao, BS
1, Nadia Abdo, DO
2, Ricardo M. Munarriz, MD
2, David S. Wang, MD
2.
1Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA, 2Boston Medical Center, Boston, MA, USA.
The humble string: the impact of ureteral stent string extraction on patient cost savings and travel emissions
Grant L. Steele, MD1, Alisa K. Sivapiromrat, BS
2, Xiu Liu, MS
1, Preeti Chachlani, MS
1, Avinash Maganty, MD, MS
1, Michelle Kim, MD, PhD
1.
1Massachusetts General Hospital, Boston, MA, USA, 2Harvard Medical School, Boston, MA, USA.
Reducing Bleeding inAquablation: The Role of Tranexamic Acid
Daniel J. Pohl, MD, BA, Shannon McNall, MD, Rachael Gotlieb, MD, Arthur Mourtzinos, MD.
Lahey Clinic, Burlington, MA, USA.
Implementation of an Artificial Intelligence-Enabled Preoperative Risk Screening Workflow to Identify High-Risk Older Adults Undergoing Urologic Surgery for Perioperative Optimization
Emma Askew, BS
1,
Emily Huang, MD2, Rory Maher, MS
3, Patrick Purdon, PhD
4, Nnamdi Onochie, BS
2, Masaya Higuchi, MD
1, Hiroko Kunitake, MD, MPH
1, Matthew Mossanen, MD, MPH
2.
1Massachusetts General Hospital, Boston, MA, USA, 2Massachusetts General Brigham, Boston, MA, USA, 3Harvard Medical School, Boston, MA, USA, 4Stanford University School of Medicine, Palo Alto, CA, USA.
3:30 pm - 4:00 pm
COFFEE BREAK
Ballroom B
4:00 pm - 4:30 pm
STATE OF THE ART LECTURE I: Novel Xiaflex Protocol
Ballroom C
Petar Bajic
4:30 pm - 5:30 pm
SOCIOECONOMIC SESSION I:
Ballroom C
5:30 pm - 6:00 pm
POINT COUNTERPOINT: Testosterone Replacement
Therapy for Patient with Prostate Cancer
Ballroom C
6:00 pm - 7:00 pm
WELCOME RECEPTION IN EXHIBIT HALL
Ballroom B
FRIDAY, OCTOBER 23, 2026
7:00 am - 8:00 am
CONTINENTAL BREAKFAST
Ballroom B
7:00 am - 8:00 am
SYMPOSIUM BREAKFAST
Mtg Room 24/25
8:00 am - 10:30 am
CONCURRENT APP PROGRAMMING
Mtg Room 26/27
8:00 am - 9:00 am
HOT TOPICS IN UROLOGY
Ballroom C
(15 Minute Talks)
- Transperineal vs. Transrectal Prostate Biopsy
- PTNS
- Rapid Expansion of Minimally Invasive BPH Therapies
- Male Infertility and Sperm Quality Crisis
9:00 am - 10:30 am
SCIENTIFIC SESSION 4: Oncology II
Ballroom C
(5 minute presentation, 2 minute discussion)
Topline Results From BOND-003 Cohort P- A Multi-National, Single-Arm Study of Intravesical Cretostimogene Grenadenorepvec for Treatment of High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with HG Ta/T1 (Without CIS)?
Timothy N. Clinton, MD1, Siamak Daneshmand, MD
2, Timothy D. Lyon, MD
3, Ankeet M. Shah, MD
4, Trinity J. Bivalacqua, MD, PhD
5, Amy N. Luckenbaugh, MD
6, Colin P.N. Dinney, MD
7, Mark Tyson, MD
8.
1Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, USA, 2University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA, 3Mayo Clinic, Jacksonville, FL, USA, 4Duke University Medical Center, Durham, NC, USA, 5University of Pennsylvania, Philadelphia, PA, USA, 6Vanderbilt University, Nashville, TN, USA, 7University of Rochester, Rochester, NY, USA, 8Mayo Clinic, Phoenix, AZ, USA.
Durable 24-Month Outcomes From BOND-003 Cohort C: Phase 3 Study of Intravesical Cretostimogene Grenadenorepvecfor High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in Situ?
Mark A. Preston, MD, MPH1, Roger Li, MD
2, Shreyas S. Joshi, MD
3, Trinity J. Bivalacqua, MD, PhD
4, Gary D. Steinberg, MD
5, Mark D. Tyson, MD, MPH
6.
1Dana Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, USA, 2H. Lee Moffitt Cancer Center, Tampa, FL, USA, 3Emory University School of Medicine, Atlanta, GA, USA, 4University of Pennsylvania, Philadelphia, PA, USA, 5Rush University Medical Center, Chicago, IL, USA, 6Mayo Clinic, Phoenix, AZ, USA.
Safety Profile Of Ugn-102 In The Treatment Of Adult Patients With Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
Sandip M. Prasad, MD
1, Neal D. Shore, MD
2, Brian Hu, MD
3,
William C. Huang, MD4, Michael J. Louie, MD, MPH, MSC
5, Nikky Ugwuoke, PharmD, MPH
5, Victoria Tsurutis, PharmD, BCPS, BCMAS
5, Brent Burger, MSc, MBA
5, Mark Schoenberg, MD
6.
1Morristown Medical Center/Atlantic Health System and Garden State Urology, Morristown, NJ, USA, 2Carolina Urologic Research Center, Myrtle Beach, SC, USA, 3Loma Linda University, Loma Linda, CA, USA, 4NYU Langone Urology Associates, New York, NY, USA, 5UroGen Pharma, Princeton, NJ, USA, 6UroGen Pharma, Princeton, NJ, USA, and The Department of Urology, Montefiore Einstein, Bronx, NY, USA.
Disproportionality Analysis of Bladder Cancer Risk with Pioglitazone Use in VigiBase: Implications for Bladder Cancer Monitoring and Treatment
Jonathan J. Song, BA
1,
Nancy Donohoo, BA1, Mark A. Preston, MD
2, Daniel A. Wollin, MD
2.
1Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA, 2Brigham and Women's Hospital, Boston, MA, USA.
Surgeon Impact on Radical Cystectomy Outcomes: A Two-Institution Analysis
Adam Jeffrey Cole, MD1, Randie White, MD
2, Emilie Platteter, BS
3, Evelyn James, BA, MPH
1, Stephen Ryan, MD
1, Matthew Hayn, MD
1, Jesse Sammon, DO
1, Vitaly Margulis, MD
4, Jeffrey Howard, MD, PhD
1.
1Maine Medical Center, Portland, ME, USA, 2Vanderbilt, Nashville, TN, USA, 3University of New England, Portland, ME, USA, 4University of Texas Southwestern Medical Center, Dallas, TX, USA.
Dementia and Frailty Impact Postoperative Care Trajectories and Burden among Older Adults Undergoing Radical Cystectomy for Bladder Cancer
John Ernandez, MD1, Lingwei Xiang, MPH
2, Rachel Adler, ScD, RD
2, John Hsu, MD
3, Samir Shah, MD
4, Dae Kim, MD, ScD
5, Boris Gershman, MD
6, Matthew Mossanen, MD, MPH
1, Joel Weissman, PhD
2.
1Department of Urology, Brigham and Women's Hospital, Boston, MA, USA, 2Center for Surgery and Public Health, Boston, MA, USA, 3Mass General Research Institute, Massachusetts General Hospital, Boston, MA, USA, 4Division of Vascular Surgery, University of Florida, Gainesville, FL, USA, 5Hebrew SeniorLife, Marcus Institute for Aging Research, Boston, MA, USA, 6Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Baseline Gleason Pattern 4 Length Associated with Recurrence after Primary Focal Ablation for Grade Group 2 Prostate Cancer Cohort
Anthony Zhang, BS, Christopher Hayden, MD, Nethusan Sivanesan, BS, Andrea Lopez-Sanmiguel, MD, Preston C. Sprenkle, MD.
Yale University School of Medicine, New Haven, CT, USA.
Clinically Significant Prostate Cancer in Patients with PI-RADS 3 Lesions: Does Lesion Size Correlate?
Austin Freedman, BA
1,
Theodoros Karanikolas, BA1, Sandra Yu, BA
2, Morgan Joseph, BS
1, Kelli Aibel, MD
1, Kara Watts, MD
1, Stephen Reese, MD
1.
1Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA, 2Albert Einstein College of Medicine, Bronx, NY, USA.
Pathologic Upgrading in Biopsy Grade Group 1, PI-RADS ?3 Prostate Cancer: Factors Associated with Clinically Significant Disease on Radical Prostatectomy
Alfred Anthony Barney, IV, MS, Shulin Wu, MD, PhD, Adam S. Feldman, MD, MPH, Chin-Lee Wu, MD, PhD, Douglas M. Dahl, MD.
Massachusetts General Hospital, Boston, MA, USA.
To Pet Or Not: Evaluating The Appropriateness Of Psma Pet Scans In Unfavorable Intermediate Risk Prostate Cancer
Mahan Najhawan, MD1, Edward Hawke, DO
2, Deeba Zadeh, BS
3, Cole Astin, BS, MPH
3, Evan Sinnathamby, MD
2, Emma Hillis, MSPH
2, Sean Collins, MD
2, Michael Maddox, MD
2, Kyle Rose, MD
2, Stephen Bardot, MD
2, Vani Vijayakumar, MD
2, Rohith Arcot, MD
2.
1UMass Chan/Ochsner Clinic Foundation, Worcester, MA, USA, 2Ochsner Clinic Foundation, New Orleans, LA, USA, 3University of Queensland - Ochsner Clinical School, New Orleans, LA, USA.
Impact Of Educational Level On Decision-Making In Low-Risk Prostate Cancer Patients In Puerto Rico: A Validated Questionnaire-Based Comparative Study
Ana Sof a Vel zquez L pez, ScM1, Guillermo Gonzalez Figueroa, MD
2.
1UMass Chan, Worcester, MA, USA, 2St Lukes Episcopal Hospital, Ponce, PR, USA.
Prognostic Significance of PSA Density Within 2026 NCCN Risk Stratification System After Radical Prostatectomy
Abdullah Salama, BS1, Tara McLaughlin Proto, PhD
2, Ilene Staff, PhD
2, Kevin Pinto, BS
2, Laura Olivo Valentin, BS
2, Joseph Tortora, MS
2, Joseph Wagner, MD
2.
1UConn Health, Farmington, CT, USA, 2Hartford Healthcare, Hartford, CT, USA.
10:30 am - 11:00 am
COFFEE BREAK
Ballroom B
11:00 am - 11:30 am
CONCURRENT APP PROGRAMMING
Mtg Room 26/27
11:00 am - 11:30 am
CONCURRENT SOCIOECONOMIC SESSION II
Ballroom C
11:30 am - 11:50 am
PRESIDENTIAL ADDRESS
Ballroom C
11:50 am - 12:30 pm
LEADBETTER LECTUR
Ballroom C
Inderbir Gill
12:30 pm - 12:45 pm
SES UPDATES: Urology PAC
Ballroom C
12:45 pm - 1:45 pm
LUNCH SYMPOSIUM
1:45 pm - 2:15 pm
BUSINESS MEETING
Ballroom C
2:15 pm - 6:00 pm
CONCURRENT APP PROGRAMMING
Mtg Room 26/27
2:15 pm - 3:45 pm
CONCURRENT SCIENTIFIC SESSION V: Trauma, Recon, Female Urology and Transgender
Ballroom C
(5 minute presentation, 2-minute discussion)
Dose-Response Relationship Between Food Insecurity Severity and Lower Urinary Tract Symptom Subtypes: A Nationally Representative Cross-Sectional Study
Aaron M. Seto, BA1, Andrew Yang, BS
1, Michael Sheen, BS
1, Jack Mulcrone, BS
1, Taemin Kim, BS
1, Meredith Wasserman, MD, MS
2.
1Warren Alpert Medical School of Brown University, Providence, RI, USA, 2Department of Urology, Brown University Health, Providence, RI, USA.
Association of Preoperative Frailty and Postoperative Morbidity Among Patients Undergoing Urinary Diversion for Refractory Lower Urinary Tract Dysfunction
John Ernandez, MD1, Vanessa Lukas, MD
1, Juntao Yu, PhD
2, Yu Zheng, MD
1.
1Department of Urology, Brigham and Women's Hospital, Boston, MA, USA, 2Whitehead Institute for Biomedical Research, Howard Hughes Medical Institute, Cambridge, MA, USA.
Early Feedback on a Goals-Based Decision Support Aid for Metoidioplasty and Phalloplasty Surgeries (MaPS)
Lee Keating Brown, BA1, Christopher Tirrell, PhD
2, Rebecca Butcher, MS, MPH
2, Glyn Elwyn, MD, PhD, MSc
3, Rachel A. Moses, MD, MPH
1.
1Geisel School of Medicine at Dartmouth, Hanover, NH, USA, 2The Center for Program Design and Evaluation (CPDE), The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA, 3The Coproduction Laboratory, The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Hanover, NH, USA.
Outcomes of Peritoneal Flap Vaginoplasty for Transgender Women: A Systematic Review of the Literature
Phuong-Uyen Catherine Tran, BS1, Hadis Askari, BS
2, Rachel Bluebond-Langner, MD
3, Lee C. Zhao, MD, MS
3.
1UMass Chan School of Medicine, Worcester, MA, USA, 2Texas Tech University Health Sciences Center School of Medicine, Austin, TX, USA, 3New York University, New York, NY, USA.
Ex-Vivo Ureteroscopy for Stone Retrieval in Kidney Allograft on Hypothermic Machine Perfusion: Is There a Benefit?
Xinyue Cynthia Tan, MD1, Gregory Kunkel, MD
2, Igor Sorokin, MD
1.
1UMass Chan Medical School, Worcester, MA, USA, 2St. Luke's University Health Network, Bethlehem, PA, USA.
Trends in Reconstructive and Prosthetic Urologic Procedures Among Medicare Beneficiaries, 2013-2023
Emma Harwood, MD, Lily C. Wang, MD, PhD, Graham T. VerLee, MD.
Maine Medical Center, Portland, ME, USA.
Constraining Large Language Models to Clinical Algorithms for Safer, Evidence-Based Clinical Decision Support
Ashti Shah, MD1, Ajay Patel, PhD
2, Marianne Casilla-Lennon, MD
1, Michael Leapman, MD
1, Joshua Sterling, MD
1.
1Yale University, New Haven, CT, USA, 2University of Pennsylvania, Philadelphia, PA, USA.
Clinical Utility of Artificial Intelligence and ChatGPT in Adherence to American Urologic Association Guidelines Across Urologic Conditions
Joseph Liao, BS
1, Karen Li, BS
1, Jane Choe, BS
1,
Sydney Look-Why, BA1, Daniel Givner, MD
2, David Wang, MD
2.
1Chobanian and Avedisian Boston University School of Medicine, Boston, MA, USA, 2Boston Medical Center, Boston, MA, USA.
First Generation and Low Income Individuals in Urology: Analysis of the 2024 AUA Census Data
Brandon Ward, MD1, Sijin Zheng, MD, PhD
1, William D. Meeks, MA
2, Alexis Helsel, PhD, MPH
2, Jaime A. Cavallo, MD, MPHS, FACS
1.
1Yale School of Medicine, New Haven, CT, USA, 2American Urological Association, Linthicum, MD, USA.
Impact of Frailty on Postoperative Outcomes After Sling Surgery
Jessica Dobler, MD1, Sidney Gregorek, BS
1, Angelina Kuzina, BS
1, Mohammad Mohaghegh, MD
1, Garson Chan, MD
2.
1University of Vermont Medical Center, Burlington, VT, USA, 2University of Saskatchewan, Saskatoon, SK, Canada.
3:45 pm - 4:15 pm
COFFEE BREAK
Ballroom B
3:45 pm - 5:00 PM
CONCURRENT APP PROGRAMMING:
Mtg Room 26/27
4:15 pm - 4:45 pm
STATE OF THE ART LECTURE II
Ballroom C
Larissa Rodriguez
4:45 pm - 5:15 pm
YOUNG UROLOGY FORUM
Ballroom C
5:15 pm - 6:15 pm
NEAUA and SWIU WOMEN IN UROLOGY SESSION
Ballroom C
7:00 pm - 10:00 pm
PRESIDENTIAL CELEBRATION
Wadsworth Museum
SATURDAY, OCTOBER 24, 2026
7:00 am - 8:00 am
CONTINENTAL BREAKFAST
Ballroom B
7:00 am - 8:00 am
SYMPOSIUM BREAKFAST
Mtg Room 26/27
7:00 am - 8:00 am
CHIEF RESIDENT BREAKFAST
Mtg Room 24/25
8:00 am - 9:30 am
SCIENTIFIC SESSION VI: Oncology II
Ballroom C
(5 minute presentation, 2 minute discussion)
Persisting Sex Disparities in Bladder Cancer Outcomes over Time: A Population-Based SEER Study
Liang G. Qu, MD
1, Lorelei Mucci, MPH
2,
Labeeqa Khizir, MD3, Steven L. Chang, MD
3, Adam Feldman, MD
3, Adam S. Kibel, MD
3, Matthew Mossanen, MD
3.
1Austin Health, Heidelberg, Australia, 2Harvard T.H. Chan School of Public Health, Boston, MA, USA, 3Brigham and Women's Hospital, Boston, MA, USA.
Clinical and Pharmacokinetic/Pharmacodynamic Insights From CORE-008 Cohort A-Phase 2 Study of Intravesical Cretostimogene Grenadenorepvecin Patients with High-Risk BCG-Na ve Non-Muscle Invasive Bladder Cancer
Matthew Mossanen, MD1, Colin P.N. Dinney, MD
2, Shane M. Pearce, MD
3, Laurence H. Belkoff, DO
4, Brian C. Mazzarella, MD
5, Christopher M. Pieczonka, MD
6, Neal D. Shore, MD
7, Jonathan Henderson, MD
8, Siamak Daneshmand, MD
9, Gary D. Steinberg, MD
10, Trinity J. Bivalacqua, MD, PhD
11.
1Dana Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, USA, 2University of Rochester Medical Center, Rochester, NY, USA, 3Spokane Urology, Spokane, WA, USA, 4MidLantic Urology, Bala Cynwyd, PA, USA, 5Urology Austin, Austin, TX, USA, 6Associated Medical Professionals of New York (an affiliate of US Urology Partners), Syracuse, NY, USA, 7START Carolinas/Carolina Urologic Research Center, Myrtle Beach, SC, USA, 8Arkansas Urology, Little Rock, AR, USA, 9University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA, 10Rush University Medical Center, Chicago, IL, USA, 11University of Pennsylvania, University of Pennsylvania, PA, USA.
Re-Evaluating Prophylactic Mesh in Radical Cystectomy: No Reduction in Parastomal Hernia Formation
Adam Cole, MD1, Maya Eldin, MD, MPH
1, Randie White, MD
2, Evelyn James, MPH
1, Jeffery Howard, MD, PhD
1, Stephen Ryan, MD
1, Matthew Hayn, MD
1, Jesse Sammon, DO
1.
1Maine Medical Center, Portland, ME, USA, 2Vanderbilt, Nashville, TN, USA.
MiR-141-3b Expression in Urothelial Carcinoma of the Bladder and Upper Tract
Kelly Crane, MD, Kailey Hooper, BS, Travis Sullivan, MS, Kimberly M. Rieger-Christ, Ph.D.
Lahey Clinic, Burlington, MA, USA.
Comparative Patient-Reported Quality of Life After Single-Port and Multi-Port Robotic Partial Nephrectomy in the Initial Post-Operative Period
Ankur Choksi, MD,
Gabriela Nieto Blanco, M.S., Graham Kupsaw, B.S., Sarah Duncan, B.A., Andrew Wagner, MD, Peter Chang, MD MPH.
Beth Israel Deaconess Medical Center, Boston, MA, USA.
CEUS Bosniak Classification of Indeterminate Renal Cysts: Single-Institution Experience
Louis Mazzarelli, MD, Joseph Renzulli, MD, Joseph Brito, MD, Timothy Tran, MD.
Lawrence and Memorial and Westerly Hospitals, Yale New Haven Health, New London, CT, USA.
Efficacy and Safety of Intravesical Cretostimogene Grenadenorepvec Plus Gemcitabine in High-Risk BCG-Exposed Or BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer (CORE-008 Cohort CX)
Boris Gershman, MD1, Aaron Berger, MD
2, Mark D. Tyson, MD, MPH
3, Christopher M. Pieczonka, MD
4, Kyle Rose, MD
5, Gary D. Steinberg, MD
6, Siamak Daneshmand, MD
7, Colin P.N. Dinney, MD
8, Trinity Bivalacqua, MD
9.
1Beth Israel Deaconess Medical Center,, Boston, MA, USA, 2Associated Urological Specialists, Chicago Ridge, IL, USA, 3Mayo Clinic, Phoenix, AZ, USA, 4Associated Medical Professionals of New York (an affiliate of US Urology Partners), Syracuse, NY, USA, 5Oschner Medical Center, New Orleans, LA, USA, 6Rush University Medical Center, Chicago, IL, USA, 7University of Southern California/Norris Comprehensive Cancer Center, Los Angele, CA, USA, 8University of Rochester, Rochester, NY, USA, 9University of Pennsylvania, Philadelphia, PA, USA.
Erectile Function Recovery After Focal Therapy Comparable Between Cryoablation and Irreversible Electroporation
Anthony Zhang, BS, George Tawfellos, MD, Louis Forgione, BS, Andrea Lopez-Sanmiguel, MD, Stanton Honig, MD, Preston C. Sprenkle, MD.
Yale University School of Medicine, New Haven, CT, USA.
Gene Specific Prostate Cancer Incidence Among Individuals with Lynch Syndrome
Joseph Boyle, MD1, Brittany Sears, PhD
2, Katherine Crawford, MS, CGC
2, Kristina Garcia, MGC, CGC
2, Linda Rodgers-Fouch , MGC, CGC
3, Keyan Salari, MD PhD
1.
1Massachusetts General Hospital, Boston, MA, USA, 2Ambry Genetics, Aliso Viejo, CA, USA, 3Mass General Brigham Cancer Institute, Boston, MA, USA.
Benign but Burdensome: Complications and Management of Benign Prostatic Hyperplasia during Active Surveillance in a Large Cohort
Ashley Monaco, DO
1,
Sara S. Koh, BS1, Andrew Guo, BS
1, Rebekka Garcia, MPH
2, Taryn Ellis, MD
2, Stephen Palasi, MD
1, Tarek Lawen, MD
2, Rodrigo Donalisio da Silva, MD
1, Justin Gregg, MD
2.
1McGovern Medical School, Houston, TX, USA, 2MD Anderson Cancer Center, Houston, TX, USA.
Biopsy Gleason Pattern 4 Burden Improves Prediction of Adverse Pathology and 3-Year Biochemical Recurrence After Radical Prostatectomy
Theodoros Karanikolas, BA1, Austin Freedman, BS
1, Jonah Tripp, BA, MPH
2, Morgan Joseph, BS
1, Samuel Yim, MD
1, Stephen Reese, MD
1, Kara Watts, MD
1.
1Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY, USA, 2Albert Einstein College of Medicine, Bronx, NY, USA.
Cribriform/Intraductal Carcinoma Exhibits Superior Prognostic Value Over Gleason Pattern 4 percentage and Tertiary Pattern 5 in Gleason Pattern 4 Prostate Cancer
Alfred Anthony Barney, IV, MS1, Chaojiang Chen, MD
2, Xiaoyang Liu, MD
3, Shulin Wu, MD, PhD
1, Sharron X. Lin, PhD
1, Adam S. Feldman, MD, MPH
1, Chin-Lee Wu, MD, PhD
1, Douglas M. Dahl, MD
1.
1Massachusetts General Hospital, Boston, MA, USA, 2The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China, 3Peking University People's Hospital, Beijing, China.
8:00 am - 9:30 am
CONCURRENT POSTER SESSION III: Benign
Mtg Room 24/25
(30 min viewing, 2-min presentation, 2-min discussion)
Use of 0.05% Chlorhexidine Gluconate Is Associated with Inflatable Penile Prosthesis Wound Complidations in a Multi-Institutional Cohort
Benjamin H. Rosenfeld, MD1, Martin S. Gross, MD
1, David Han, MD
2, Muhammed Hammad, MBBCh
3, Samuel Ivan, MD
2, Elia Chawareb, MD
3, Faysal Yafi, MD
3, Thairo Pereria, MD
4, Jacob Good, MD
5, Helen Bernie, DO
5, Nicklas Sarantos, MD
6, Aaron Lentz, MD
6, Alredo Suarez-Sarmiento, MD
7, Paul Perito, MD
7, Joshua Schammel, MD
8, Charles Welliver, MD
8, Zayda Dominick, MD
9, Ketch Cowan, MD
9, Anand Shridharani, MD
9, Brian Im, MD
10, Paul Chung, MD
10, Vi Nguyen, MD
11, Michael Hsieh, MD
11, David Barham, MD
12, Jay Simhan, MD
2.
1Dartmouth Health, Lebanon, NH, USA, 2Fox Chase Cancer Center, Philadelphia, PA, USA, 3University of California Irvine, Irvine, CA, USA, 4University of Rochester Medical Center, Rochester, NY, USA, 5Indiana University Health, Indianapolis, IN, USA, 6Duke Health, Durham, NC, USA, 7Perito Urology, Coral Gables, FL, USA, 8Albany Med Health System, Albany, NY, USA, 9Erlanger Health System, Chattanooga, TN, USA, 10Jefferson Health, Philadelphia, PA, USA, 11University of California San Diego, San Diego, CA, USA, 12Brooke Army Medical Center, Fort Sam Houston, TX, USA.
Accuracy of Bladder Capacity Measurements in Children with Bladder Exstrophy Epispadias Complex: Does the Measurement Modality Matter?
Noa Ferziger, BA, Evalynn Vasquez, MD, MBA, Richard Lee, MD, Ted Lee, MD, MSc.
Boston Children's Hospital, Boston, MA, USA.
Anticipating Pain: Investigating Patients' Predictive Abilities during Cystoscopy
Andrew Harper Williams, MD, Thaise Uzeda, MD, Jaleta Ahmed, BS, Boris Gershman, MD, Eric Macdonald, MD, Benjamin Green, MD, Heidi Rayala, MD, PhD.
BIDMC, Boston, MA, USA.
Rates of Emergency Department Presentation for Priapism in the Era of Direct-to-Consumer Telemedicine
Phuong-Uyen Catherine Tran, BS, Xinyue C. Tan, MD, Winna Xia, MS, Rachel B. Engelberg, MD.
UMass Chan School of Medicine, Worcester, MA, USA.
Postoperative Delirium in Major Urologic Surgery: Procedure-Specific Risk Factors and Impact on 30-Day Outcomes
Boyuan Xiao, BA1, Jonathan J. Song, BA
1, Nancy G. Donohoo, BA
1, Alexander P. Cole, MD
2, David S. Wang, MD
1.
1Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA, 2Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
A Decade of NIH Funding in Urology: Trends and Patterns from 2015-2024
Arthur Yu, BA, Ryan Schumann, BS, Adrian Bozocea, BS, Amogh Gadekar, BS, Pierce Bagby, BS, Vinata B. Lokeshwar, PHD.
Medical College of Georgia, Augusta, GA, USA.
Inside the 2026 Urology Match: Program Director Insights on Selection and Ranking
Esther Chung, BS1, Katherine Wu, DO, MA
2, Kathleen Kobashi, MD, MBA, FACS
3, Marianne Casilla-Lennon, MD
4.
1Frank H Netter SOM at Quinnipiac University, North Haven, CT, USA, 2McLaren Macomb Hospital Department of Urology, Mt Clemens, MI, USA, 3Houston Methodist Hospital Department of Urology, Houston, TX, USA, 4Yale University Department of Urology, New Haven, CT, USA.
Comparing Differences in Sacral Neuromodulation Device Management in Patients with Neurogenic Lower Urinary Tract Dysfunction versus Non-Neurogenic Conditions
Architha Sudhakar, MD1, Emma Harwood, MD
1, Madeleine Powers, BS
2, Evelyn James, MPH
1, Sanchita Bose, MD
1.
1Maine Medical Center, Portland, ME, USA, 2University of New England Osteopathic College of Medicine, Biddeford, ME, USA.
Early Complications After BPH Interventions: A Prospective Comparative Study of TURP,HoLEP,Aquablation, and PAE
Julian Giakas, MD, Thaise Sestelo Uzeda, MD, Ra'ad Al-Faouri, MD, Andrew Williams, MD, Jaleta Ahmed, MPH, Christian Schaufler, MD, Michelleq Shabo, MD, Eric MacDonald, MD, Shaun Wason, MD, Ruslan Korets, MD, Heidi J. Rayala, MD, PhD.
Beth Israel Deaconess Medical Center, Boston, MA, USA.
The Paradox of Severe Baseline LUTS: Predictors of Early Satisfaction After ThuFLEP
Jack Edward Mulcrone, BA, Daniel Sanford, MD, Jarrett Noakes, BS, Raymond Chiang, BS ScM, Andrew Tompkins, MD, Samuel Eaton, MD.
The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Clinical And Functional Outcomes Following Aquablation: A Four-Year Analysis
Daniel Pohl, MD, BA, Rachael Gotlieb, MD, Shannon McNAll, MD, Arthur Mourtzinos, MD.
Lahey Clinic, Burlington, MA, USA.
Post-HoLEP Decisional Regret: A Mixed-Methods Analysis
Benjamin Greenfield, BS, MS1, Mubarak Momodu, BA
2, Feres Maluf, MD
3, Lynn Leng, MS
2, Ethan Wan, MPH
2, Vicente E. Decombe, MD
3, Joel T. Funk, MD
3, Kazumi Taguchi, MD
3, Karishma Gupta, MD
3, Max Bowman, MD
2, Thomas Chi, MD
3.
1Tufts University School of Medicine, Boston, MA, USA, 2University of California, San Francisco, San Francisco, CA, USA, 3University of Alabama at Birmingham, Birmingham, AL, USA.
Spatially Defined SRD5A2-Independent Stromal Niches Predict 5ARI Response in Benign Prostatic Hyperplasia
Xingbo Long, M.D., Zahra Ansari, Ph.D., Aaron Fleishman, M.D., Ruslan Korets, M.D., Boris Gershman, M.D., Heidi J Rayala, M.D., Yue Sun, M.D., Aria F Olumi, M.D..
Beth Israel Deaconess Medical Center, Boston, MA, USA.
9:30 am - 10:00 am
COFFEE BREAK
Ballroom B
10:00 AM - 10:30 AM
YUO Lecture Speaker:
Ballroom C
Saum Ghodoussipour
10:30 AM - 11:15 AM
YUO PANEL: Management of advanced bladder cancer after response to IO
Ballroom C
11:15 am - 12:15 pm
VIDEO ABSTRACT SESSION
Ballroom C
(5 minute video, 5 minute discussion)
Corporal Dissection of the Kelly Repair
Ted Lee, Noa Ferziger, Joseph Borer, Evalynn Vasquez, Richard Lee.
Boston Children's Hospital, Boston, MA, USA.
Urothelial Carcinoma Recurrence Within an Ileal Conduit- Surgical Resection with the Single-Port Robot
Eric J. Macdonald, MD1, Sina Monfared, MD
2, Christian Schaufler, MD
2, Peter Chang, MD, MPH
2.
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2BIDMC, Boston, MA, USA.
Double Trouble: Upper Tract Urothelial Carcinoma in an Obstructed Duplicated System
Elisa Rocha, MD, Cairo Stanislaus, Daniela Diaz Rubayo, Jennifer Yates.
UMass Chan Medical School, Worcester, MA, USA.
Endoscopic Incision and Fulguration of a Complex Urethral Diverticulum with a Stone
Laura Maciejko, M.D., James McAndrew Jones, M.D., Toby C. Chai, M.D..
Boston Medical Center / Boston University, Boston, MA, USA.
Single-port Cystectomy and Ileal Conduit in a Hostile Abdomen
Eric J. Macdonald, MD, Peter Chang, MD, MPH.
Beth Israel Deaconess Medical Center, Boston, MA, USA.
Ventral Rotational Flap with Dartos Buttonhole Modification
Ted Lee, Noa Ferziger, Genevieve Wagner, Joseph Borer, Evalynn Vasquez, Richard Lee.
Boston Children's Hospital, Boston, MA, USA.
